Dr. Berg highlights key ongoing trials in urothelial cancer

Video

Stephanie Berg, DO, highlights key ongoing trials in advanced/metastatic urothelial cancer, including EV-302 (NCT04223856), NILE (NCT03682068) CheckMate-901 (NCT03036098), and MAIN-CAV (NCT05092958).Berg is an instructor of medicine, Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute.

Related Videos
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Scott T. Tagawa, MD, MS, FACP, FASCO, an expert on bladder cancer
Dr. Kyle A. Richards in an interview with Urology Times
3d rendered illustration - bladder cancer | Image Credit: © SciePro - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.